Tuesday, November 24, 2009, 8:37pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

TranS1, Inc. (TSON)

At 5:00AM SGT: 3.65 USD   0.00 (0.00%)  
 MORE ON TSON 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 TranS1 Inc. (NGM:TSON) Delayed quote dataEdit
Last Trade:3.65 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:3.65
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:8.50
Day's Range:N/A - N/A
52wk Range:3.47 - 8.74
Volume:0
Avg Vol (3m):63,823.1
Market Cap:75.32M
P/E (ttm):N/A
EPS (ttm):-1.07
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add TSON to Portfolio   Download Data

 HEADLINES 
•TRANS1 INC Financials
EDGAR Online Financials (Wed, Nov 11)
•TRANS1 INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 7)
•TRANS1 INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Nov 4)
•TranS1 Inc. Reports Operating Results for the Third Quarter of 2009
GlobeNewswire (Fri, Oct 30)
•Q3 2009 TranS1, Inc. Earnings Release - After Market Close
CCBN (Thu, Oct 29)
•TranS1 Inc. Schedules Third Quarter 2009 Earnings Release and Conference Call for Thursday, October 29, 2009
GlobeNewswire (Sat, Oct 24)
•Insider Sarah Smith Sells $3M Worth of Goldman Sachs
TheStreet.com (Thu, Oct 22)
•TranS1 Trims Third Quarter Outlook
Zacks.com (Thu, Oct 15)
•TRANS1 INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Sat, Oct 10)
•TranS1 cuts 3Q revenue goal on weak AxiaLIF sales
AP (Wed, Oct 7)
•TranS1 Inc. Announces Preliminary Revenue Results for Third Quarter
GlobeNewswire (Wed, Oct 7)
More Headlines for TSON...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.20
EPS Est (in 2 years) (Dec-10) :-1.08
Avg Rec (current)*:2.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
TranS1 Inc., a medical device company, focuses on the design, development, and marketing of products that implement its proprietary surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices